U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H29ClN6O5
Molecular Weight 528.988
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZD-0424

SMILES

CC(C)OC1=CC(OCCN2CCN(CC2)C(C)=O)=CC3=C1C(NC4=C5OCOC5=NC=C4Cl)=NC=N3

InChI

InChIKey=MVWATCATLSSVBH-UHFFFAOYSA-N
InChI=1S/C25H29ClN6O5/c1-15(2)37-20-11-17(34-9-8-31-4-6-32(7-5-31)16(3)33)10-19-21(20)24(29-13-28-19)30-22-18(26)12-27-25-23(22)35-14-36-25/h10-13,15H,4-9,14H2,1-3H3,(H,27,28,29,30)

HIDE SMILES / InChI

Molecular Formula C25H29ClN6O5
Molecular Weight 528.988
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

AZD0424, a dual selective Src/Abl kinase inhibitor that has shown evidence of anti-tumor activity in pre-clinical studies. AZD0424 participated in phase I clinical trials in patients with advanced solid tumors, but this study was terminated because of insufficient evidence of efficacy as monotherapy.

Approval Year

PubMed

PubMed

TitleDatePubMed
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors.
2015 Apr
Patents

Sample Use Guides

AZD0424 will be administered as a flat dose orally once a day. One treatment cycle consists of 28 days of continuous drug administration with AZD0424, with the flexibility to introduce treatment breaks if required due to cumulative toxicity.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:49:46 UTC 2023
Edited
by admin
on Sat Dec 16 10:49:46 UTC 2023
Record UNII
642PS51324
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZD-0424
Common Name English
7-(2-(4-ACETYLPIPERAZIN-1-YL)ETHOXY)-4-(5-CHLORO-2,3-METHYLENEDIOXYPYRIDIN-4-YLAMINO)-5-ISOPROPOXYQUINAZOLINE
Systematic Name English
AZD0424
Code English
PIPERAZINE, 1-ACETYL-4-(2-((4-((6-CHLORO-1,3-DIOXOLO(4,5-B)PYRIDIN-7-YL)AMINO)-5-(1-METHYLETHOXY)-7-QUINAZOLINYL)OXY)ETHYL)-
Systematic Name English
ETHANONE, 1-(4-(2-((4-((6-CHLORO-1,3-DIOXOLO(4,5-B)PYRIDIN-7-YL)AMINO)-5-(1-METHYLETHOXY)-7-QUINAZOLINYL)OXY)ETHYL)-1-PIPERAZINYL)-
Systematic Name English
Code System Code Type Description
NCI_THESAURUS
C102976
Created by admin on Sat Dec 16 10:49:46 UTC 2023 , Edited by admin on Sat Dec 16 10:49:46 UTC 2023
PRIMARY
FDA UNII
642PS51324
Created by admin on Sat Dec 16 10:49:46 UTC 2023 , Edited by admin on Sat Dec 16 10:49:46 UTC 2023
PRIMARY
ChEMBL
CHEMBL3545177
Created by admin on Sat Dec 16 10:49:46 UTC 2023 , Edited by admin on Sat Dec 16 10:49:46 UTC 2023
PRIMARY
CAS
692054-06-1
Created by admin on Sat Dec 16 10:49:46 UTC 2023 , Edited by admin on Sat Dec 16 10:49:46 UTC 2023
PRIMARY
DRUG BANK
DB13088
Created by admin on Sat Dec 16 10:49:46 UTC 2023 , Edited by admin on Sat Dec 16 10:49:46 UTC 2023
PRIMARY
PUBCHEM
9893171
Created by admin on Sat Dec 16 10:49:46 UTC 2023 , Edited by admin on Sat Dec 16 10:49:46 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
INHIBITOR